These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14517746)

  • 1. The fibrinolytic system in children.
    Albisetti M
    Semin Thromb Hemost; 2003 Aug; 29(4):339-48. PubMed ID: 14517746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibrinolytic system in newborns and children.
    Parmar N; Albisetti M; Berry LR; Chan AK
    Clin Lab; 2006; 52(3-4):115-24. PubMed ID: 16584057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
    Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK
    Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis and the risk of venous and arterial thrombosis.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental hemostasis: relevance to hemostatic problems during childhood.
    Andrew M
    Semin Thromb Hemost; 1995; 21(4):341-56. PubMed ID: 8747697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic system in adolescents: response to venous occlusion stress tests.
    Monagle P; Chan AK; Albisetti M; Vegh P; Andrew M; Mitchell L
    Pediatr Res; 2003 Feb; 53(2):333-7. PubMed ID: 12538795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the fibrinolytic system in the newborn].
    Schlegel N; Hurtaud-Roux MF; Beaufils F
    Ann Pediatr (Paris); 1993 Feb; 40(2):70-4. PubMed ID: 8457135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired fibrinolytic activity is present in children with dyslipidemias.
    Albisetti M; Chan AK; McCrindle BW; Wong D; Monagle P; Andrew M
    Pediatr Res; 2004 Apr; 55(4):576-80. PubMed ID: 14739372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic factors and atherothrombotic events: epidemiological evidence.
    Folsom AR
    Ann Med; 2000 Dec; 32 Suppl 1():85-91. PubMed ID: 11209988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New methods accelerate the development of thrombolytic agents].
    Wiman B; Hamsten A
    Lakartidningen; 1991 Jan; 88(1-2):37, 40-1. PubMed ID: 2002712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
    Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy in children.
    Albisetti M
    Thromb Res; 2006; 118(1):95-105. PubMed ID: 16709478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the hemostatic system in healthy preterm and fullterm newborns].
    Pinacho A; Páramo JA
    Rev Med Univ Navarra; 1993; 38(2):23-30. PubMed ID: 14735720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
    Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study.
    Kupesiz OA; Chitlur MB; Hollon W; Tosun O; Thomas R; Warrier I; Lusher JM; Rajpurkar M
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):313-9. PubMed ID: 20305541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.